Login / Signup

Intestinal Helminth Infections in Ghanaian Children from the Ashanti Region between 2007 and 2008-A Retrospective Cross-Sectional Real-Time PCR-Based Assessment.

Charity Wiafe AkentenFelix WeinreichEllis Kobina PaintsilJohn H AmuasiDennis FosuUlrike LoderstädtJürgen MayHagen FrickmannDenise Dekker
Published in: Tropical medicine and infectious disease (2022)
In spite of ongoing eradication programs, helminth infections are still a medical issue in Ghana. For follow-up assessments on the decline of regional helminth infections, historic baseline prevalence values obtained with standardized diagnostic procedures can be helpful. In this retrospective cross-sectional study, real-time PCR targeting the nematodes Ancylostoma spp. (ITS2), Ascaris lumbricoides (ITS1), Enterobius vermicularis (ITS1), Necator americanus (ITS2), Strongyloides stercoralis (18S rRNA) and Trichuris trichiura (18S rRNA), the trematodes Schistosoma spp. (ITS2) as well as the cestodes Hymenolepis nana (ITS1), Taenia saginata (ITS1) and Taenia solium (ITS1) was applied with 2046 DNA eluates from stool samples of Ghanaian children from the Ashanti region collected between 2007 and 2008 in order to retrospectively define prevalence values. The overall prevalence was low with 3.8% ( n = 77) and only 0.1% ( n = 2) double infections with helminths were recorded. The three most frequently detected enteric helminth species comprised 2% S. stercoralis ( n = 41), 0.8% H. nana ( n = 16), and 0.7% N. americanus ( n = 14), while only sporadic infection events were recorded for other helminth species comprising 0.1% E. vermicularis ( n = 2), 0.1% Schistosoma spp. ( n = 2), 0.1% T. saginata ( n = 1) and 0.1% T. trichiura ( n = 1). A. lumbricoides , Ancylostoma spp. and T. solium were not detected at all. In conclusion, the retrospective assessment suggests a low prevalence of enteric helminth infections in Ghanaian children from the Ashanti Region within the assessment period between 2007 and 2008.
Keyphrases
  • real time pcr
  • cross sectional
  • risk factors
  • young adults
  • healthcare
  • drug delivery
  • cancer therapy